Capricor Therapeutics (CAPR) EBIT Margin Growth (3y) (2014 - 2024)
Capricor Therapeutics (CAPR) EBIT Margin Growth (3y) (2014 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | - |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn | 9,942.00 |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn | -623.00 |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | 6,993.00 |
| 10 | Capricor Therapeutics | 438.80 Mn | 438.80 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 219,888.00 |
| Mar 31, 2024 | 1.25 Mn |
| Dec 31, 2023 | 721,842.00 |
| Sep 30, 2023 | 2.31 Mn |
| Jun 30, 2023 | 679,696.00 |
| Mar 31, 2023 | 86,090.00 |
| Dec 31, 2022 | -17,245.00 |
| Sep 30, 2022 | 73,866.00 |
| Jun 30, 2021 | -146,020.00 |
| Mar 31, 2021 | -1.17 Mn |
| Dec 31, 2020 | -653,956.00 |
| Sep 30, 2020 | -2.24 Mn |
| Jun 30, 2020 | -591,482.00 |
| Mar 31, 2020 | -73,013.00 |
| Dec 31, 2019 | -24,171.00 |
| Sep 30, 2019 | -44,398.00 |
| Jun 30, 2019 | 160,888.00 |
| Mar 31, 2019 | -76,284.00 |
| Dec 31, 2018 | -38,630.00 |
| Sep 30, 2018 | -119,624.00 |